Меморандум про співпрацю та взаємодію!

On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…